Johnson & Johnson Pause Covid Dose Trial As Contributor Becomes ill ….

The pause means the online enlistment system has been closed for the 60,000-sufferer clinical trial while the autonomous patient safety board is convened.


  • J & J said Monday it had for the time being block its Covid-19 dose trial because one of its participants had diseased.
  • Right now J&J  temporarily stop additional dose of Covid-19 vaccine to our stage-3 as well as on aspirants which is on clinical trials.
  • The pause method is a online enlistment system which has been break off for the sixty thousand- sufferer clinical trial .
  • Johnson & Johnson said that serious adverse events (SAEs) are “an normal part of any clinical trial, notably large studies.” Company instruction  allowed them to pause a study to complete if the SAE was related to the drug in question and whether to restart study.
  • The Johnson & Johnson stage 3 trial had started raised participants in late September, with a goal of register up to sixty thousand participant across more than 200 locations in US and around the world.
  • The other countries where the testing  were taking place are Colombia, Argentina, Chile ,Brazil,  Mexico, South Africa and Peru.


Related posts

Leave a Comment